Letters Initial drug treatment in Parkinson’s disease

Reboxetine has no antidepressant effect at all

BMJ 2015; 351 doi: http://dx.doi.org/10.1136/bmj.h5842 (Published 03 November 2015) Cite this as: BMJ 2015;351:h5842
  1. Richard Braithwaite, consultant psychiatrist1
  1. 1St Mary’s Hospital, Newport PO30 5TG, UK
  1. richard.braithwaite{at}iow.nhs.uk

Muzerengi and Clarke are correct to advise against the use of most antidepressants in combination with the monoamine oxidase B inhibitors, rasagiline and selegiline.1 But it …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe